Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Other Working Capital Changes (2016 - 2026)

Conmed filings provide 17 years of Other Working Capital Changes readings, the most recent being $17.2 million for Q1 2026.

  • On a quarterly basis, Other Working Capital Changes rose 217.5% to $17.2 million in Q1 2026 year-over-year; TTM through Mar 2026 was $25.0 million, a 98.8% increase, with the full-year FY2025 number at $13.2 million, down 5.4% from a year prior.
  • Other Working Capital Changes hit $17.2 million in Q1 2026 for Conmed, up from $225000.0 in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $17.2 million in Q1 2026 to a low of -$133000.0 in Q4 2023.
  • Median Other Working Capital Changes over the past 5 years was $4.5 million (2025), compared with a mean of $4.9 million.
  • The widest YoY moves for Other Working Capital Changes: up 3027.64% in 2023, down 102.21% in 2023.
  • Conmed's Other Working Capital Changes stood at $6.0 million in 2022, then plummeted by 102.21% to -$133000.0 in 2023, then surged by 2819.55% to $3.6 million in 2024, then plummeted by 93.78% to $225000.0 in 2025, then surged by 7551.11% to $17.2 million in 2026.
  • The last three reported values for Other Working Capital Changes were $17.2 million (Q1 2026), $225000.0 (Q4 2025), and $3.1 million (Q3 2025) per Business Quant data.